SUNOPTA INC (STKL)

CA8676EP1086 - Common Stock

5.88  -0.16 (-2.65%)

After market: 5.79 -0.09 (-1.53%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to STKL. STKL was compared to 91 industry peers in the Food Products industry. There are concerns on the financial health of STKL while its profitability can be described as average. STKL does not seem to be growing, but still is valued expensively.



4

1. Profitability

1.1 Basic Checks

STKL had positive earnings in the past year.
In the past year STKL had a positive cash flow from operations.
In the past 5 years STKL reported 4 times negative net income.
Of the past 5 years STKL 4 years had a positive operating cash flow.

1.2 Ratios

STKL has a Return On Assets of -26.44%. This is in the lower half of the industry: STKL underperforms 78.02% of its industry peers.
STKL's Return On Equity of -100.81% is on the low side compared to the rest of the industry. STKL is outperformed by 74.73% of its industry peers.
STKL has a Return On Invested Capital (5.06%) which is in line with its industry peers.
STKL had an Average Return On Invested Capital over the past 3 years of 4.69%. This is below the industry average of 7.56%.
The last Return On Invested Capital (5.06%) for STKL is above the 3 year average (4.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -26.44%
ROE -100.81%
ROIC 5.06%
ROA(3y)-9.36%
ROA(5y)-3.51%
ROE(3y)-34.91%
ROE(5y)-17.74%
ROIC(3y)4.69%
ROIC(5y)N/A

1.3 Margins

STKL has a better Operating Margin (5.23%) than 64.84% of its industry peers.
STKL's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 17.28%, STKL is in line with its industry, outperforming 45.05% of the companies in the same industry.
STKL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.23%
PM (TTM) N/A
GM 17.28%
OM growth 3Y68.62%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.9%
GM growth 5Y15.71%

0

2. Health

2.1 Basic Checks

STKL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, STKL has more shares outstanding
Compared to 5 years ago, STKL has more shares outstanding
The debt/assets ratio for STKL is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that STKL is in the distress zone and has some risk of bankruptcy.
STKL's Altman-Z score of 1.31 is on the low side compared to the rest of the industry. STKL is outperformed by 64.84% of its industry peers.
A Debt/Equity ratio of 1.36 is on the high side and indicates that STKL has dependencies on debt financing.
With a Debt to Equity ratio value of 1.36, STKL is not doing good in the industry: 81.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.59
WACC8.52%

2.3 Liquidity

STKL has a Current Ratio of 1.19. This is a normal value and indicates that STKL is financially healthy and should not expect problems in meeting its short term obligations.
STKL has a worse Current ratio (1.19) than 63.74% of its industry peers.
A Quick Ratio of 0.65 indicates that STKL may have some problems paying its short term obligations.
STKL has a Quick ratio of 0.65. This is in the lower half of the industry: STKL underperforms 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.65

3

3. Growth

3.1 Past

The earnings per share for STKL have decreased strongly by -12.50% in the last year.
Looking at the last year, STKL shows a decrease in Revenue. The Revenue has decreased by -3.46% in the last year.
Measured over the past years, STKL shows a decrease in Revenue. The Revenue has been decreasing by -4.27% on average per year.
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q150%
Revenue 1Y (TTM)-3.46%
Revenue growth 3Y-7.22%
Revenue growth 5Y-4.27%
Revenue growth Q2Q-17.93%

3.2 Future

The Earnings Per Share is expected to grow by 95.54% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.10% on average over the next years. This is quite good.
EPS Next Y83.96%
EPS Next 2Y95.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.14%
Revenue Next 2Y10.1%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 84.00 indicates a quite expensive valuation of STKL.
STKL's Price/Earnings is on the same level as the industry average.
STKL is valuated expensively when we compare the Price/Earnings ratio to 24.83, which is the current average of the S&P500 Index.
STKL is valuated quite expensively with a Price/Forward Earnings ratio of 45.66.
STKL's Price/Forward Earnings ratio is in line with the industry average.
STKL's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.32.
Industry RankSector Rank
PE 84
Fwd PE 45.66

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of STKL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.06

4.3 Compensation for Growth

STKL's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
STKL's earnings are expected to grow with 95.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y95.54%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for STKL!.
Industry RankSector Rank
Dividend Yield N/A

SUNOPTA INC

NASDAQ:STKL (4/17/2024, 7:26:51 PM)

After market: 5.79 -0.09 (-1.53%)

5.88

-0.16 (-2.65%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap682.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 84
Fwd PE 45.66
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.44%
ROE -100.81%
ROCE
ROIC
ROICexc
ROICexgc
OM 5.23%
PM (TTM) N/A
GM 17.28%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 1.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.19
Quick Ratio 0.65
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-12.5%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y83.96%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.46%
Revenue growth 3Y-7.22%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y